Related Experiment Video

Updated: Jul 13, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
09:41

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Published on: July 3, 2014

Prior statin use reduces mortality in intracerebral hemorrhage

Neeraj S Naval1, Tamer A Abdelhak, Paloma Zeballos

  • 1The Johns Hopkins Hospital, Baltimore, MD, USA. nnaval1@jhmi.edu

Neurocritical Care
|August 19, 2007
PubMed

Insights

Prior statin use may improve survival after intracerebral hemorrhage (ICH). High blood glucose levels upon admission are linked to increased mortality in ICH patients. Further research is needed.

Area of Science:

  • Neurology
  • Stroke Research
  • Clinical Outcomes

Background:

  • Intracerebral hemorrhage (ICH) has high mortality rates.
  • Known predictors of ICH survival include GCS, ICH volume, age, and IVH.
  • The impact of other clinical factors on long-term ICH outcomes requires further investigation.

Purpose of the Study:

  • To evaluate the influence of blood glucose, coagulopathy, seizures, and prior statin/aspirin use on clinical outcomes after ICH.
  • To identify key factors affecting mortality and functional recovery in ICH patients.

Main Methods:

  • Retrospective review of 125 ICH patients admitted to The Johns Hopkins Hospital (1999-2006).
  • Exclusion of trauma-related ICH, underlying lesions, and infratentorial locations.
  • Logistic regression analysis assessed the impact of admission blood glucose, coagulopathy, seizures, and prior statin/aspirin use on 30-day mortality and functional outcomes (dMRS, dGOS).

Main Results:

  • Prior statin use was associated with a significant decrease in 30-day mortality (odds of survival >12-fold).
  • Elevated admission blood glucose levels correlated with increased 30-day mortality (P=0.023).
  • Coagulopathy, seizures, and prior aspirin use did not significantly impact mortality or functional outcomes.

Conclusions:

  • Prior statin use shows a significant association with reduced mortality following intracerebral hemorrhage.
  • The findings suggest a potential protective role for statins in ICH patients.
  • Prospective studies are warranted to confirm the benefits of statin use post-ICH.
Abstract

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.